title: Synchronous del5q myelodysplastic syndrome (del5qMDS) and adult B-cell acute lymphoblastic leukemia (B-ALL) with TET2 and TP53 mutations.
authors.affiliation: M.D. Anderson Cancer Center, Department of Leukemia, the University of Texas, Houston, Texas.
authors.forename: Preetesh
authors.initials: P
authors.lastname: Jain
authors.affiliation: M.D. Anderson Cancer Center, Department of Hematopathology, the University of Texas, Houston, Texas.
authors.forename: Guilin
authors.initials: G
authors.lastname: Tang
authors.affiliation: M.D. Anderson Cancer Center, Department of Hematopathology, the University of Texas, Houston, Texas.
authors.forename: Sergej N
authors.initials: SN
authors.lastname: Konoplev
authors.affiliation: M.D. Anderson Cancer Center, Department of Hematopathology, the University of Texas, Houston, Texas.
authors.forename: Rashmi
authors.initials: R
authors.lastname: Kanagal-Shamanna
authors.affiliation: M.D. Anderson Cancer Center, Department of Hematopathology, the University of Texas, Houston, Texas.
authors.forename: Sa A
authors.initials: SA
authors.lastname: Wang
authors.affiliation: M.D. Anderson Cancer Center, Department of Leukemia, the University of Texas, Houston, Texas.
authors.forename: Naveen
authors.initials: N
authors.lastname: Pemmaraju
authors.affiliation: M.D. Anderson Cancer Center, Department of Leukemia, the University of Texas, Houston, Texas.
authors.forename: Naval
authors.initials: N
authors.lastname: Daver
authors.affiliation: M.D. Anderson Cancer Center, Department of Leukemia, the University of Texas, Houston, Texas.
authors.forename: Zeev
authors.initials: Z
authors.lastname: Estrov
mesh_terms: D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D020732:Cytogenetic Analysis; D004268:DNA-Binding Proteins / Q000235:genetics*; D049308:Dioxygenases; D005260:Female; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D015448:Leukemia, B-Cell / Q000150:complications / Q000188:drug therapy / Q000235:genetics*; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000150:complications / Q000188:drug therapy / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016896:Treatment Outcome; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*
chemical_list: D004268:DNA-Binding Proteins; D011518:Proto-Oncogene Proteins; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; D049308:Dioxygenases; C541081:TET2 protein, human